{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05907213",
            "orgStudyIdInfo": {
                "id": "STUDY22100018"
            },
            "secondaryIdInfos": [
                {
                    "id": "1R01MH134538-01",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1R01MH134538-01"
                }
            ],
            "organization": {
                "fullName": "University of Pittsburgh",
                "class": "OTHER"
            },
            "briefTitle": "Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery",
            "officialTitle": "Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE1)",
            "therapeuticArea": [
                "Mental Health",
                "Other"
            ],
            "study": "ketamine-tolerated-dose-for-postpartum-depression-and-pain-after-cesarean-delivery"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-25",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-07",
            "studyFirstSubmitQcDate": "2023-06-07",
            "studyFirstPostDateStruct": {
                "date": "2023-06-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Grace Lim, MD, MS",
                "investigatorTitle": "Associate Professor, Chief Obstetric & Women's Anesthesiology",
                "investigatorAffiliation": "University of Pittsburgh"
            },
            "leadSponsor": {
                "name": "Grace Lim, MD, MS",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Mental Health (NIMH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to identify a tolerable dose for postpartum ketamine infusion using a maximum tolerated dose (MTD) 3+3 design. A loading dose over 1 hour will be the MTD variable to be tested, as our data suggest that ketamine side effects occur with the loading dose. The investigators hypothesize that subanesthetic ketamine dose will be well tolerated and any noted side effects will be rated acceptable by postpartum women following cesarean delivery.",
            "detailedDescription": "Pain management for women having a cesarean delivery is rather limited and risks poor pain control, depressed mood, and poor recovery following the cesarean delivery. Current cesarean pain management treatments ignore the multidimensionality of pain, including the influence of mood on pain. Recent evidence suggests that ketamine may provide successful post-surgical pain management, opioid reduction, and rapid reduction of depressive symptoms. The current study aims to identify an appropriate dose of ketamine for post-cesarean pain management while minimizing potential dose-dependent side effects in women following childbirth."
        },
        "conditionsModule": {
            "conditions": [
                "Pain, Postoperative",
                "Depression, Postpartum"
            ],
            "keywords": [
                "Cesarean Delivery"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "MTD 3+3 design",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 12,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Loading dose Ketamine",
                    "type": "EXPERIMENTAL",
                    "description": "Loading dose of ketamine in 3+3 MTD for 1 hour followed by maintenance 0.05mg/kg/hr ketamine 11-hour infusion.",
                    "interventionNames": [
                        "Drug: Ketamine (Ketalar) Dose Level 1",
                        "Drug: Ketamine (Ketalar) Dose Level 2",
                        "Drug: Ketamine (Ketalar) Dose Level 3",
                        "Drug: Ketamine (Ketalar) Dose Level 4"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ketamine (Ketalar) Dose Level 1",
                    "description": "Loading Dose: 0.05 mg/kg/hr X 1 hour; Maintenance Dose 0.05 mg/kg/hr x 12 hours",
                    "armGroupLabels": [
                        "Loading dose Ketamine"
                    ],
                    "otherNames": [
                        "0.05 mg/kg/1hr loading dose Ketamine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ketamine (Ketalar) Dose Level 2",
                    "description": "Loading Dose: 0.08 mg/kg/hr X 1 hour; Maintenance Dose 0.05 mg/kg/hr x 12 hours",
                    "armGroupLabels": [
                        "Loading dose Ketamine"
                    ],
                    "otherNames": [
                        "0.08 mg/kg/1hr loading dose Ketamine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ketamine (Ketalar) Dose Level 3",
                    "description": "Loading Dose: 0.12 mg/kg/hr X 1 hour; Maintenance Dose 0.05 mg/kg/hr x 12 hours",
                    "armGroupLabels": [
                        "Loading dose Ketamine"
                    ],
                    "otherNames": [
                        "0.12 mg/kg/1hr loading dose Ketamine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ketamine (Ketalar) Dose Level 4",
                    "description": "Loading Dose: 0.18 mg/kg/hr X 1 hour; Maintenance Dose 0.05 mg/kg/hr x 12 hours",
                    "armGroupLabels": [
                        "Loading dose Ketamine"
                    ],
                    "otherNames": [
                        "0.18 mg/kg/1hr loading dose Ketamine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Maximum Tolerated Dose of ketamine",
                    "description": "Dose that fewer than 33% of patients experience intolerability",
                    "timeFrame": "Between 0 to 24 hours postpartum"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Patient reported acceptability of any reported side effects",
                    "description": "Proportion (%) of patient cohort reporting acceptability at each ketamine dose",
                    "timeFrame": "Between 0 to 24-hours postpartum"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults 18 years and older\n* Cesarean Delivery\n* American Society of Anesthesiologists Physical Status of 2 or 3\n* Neuraxial anesthesia with neuraxial morphine\n* Term delivery \u226537 weeks gestation\n* Either planning not to breastfeed, OR receiving ketamine as part of routine clinical care\n\nExclusion Criteria:\n\n* General anesthesia\n* Allergy to study medications\n* ASA PS 4 or higher\n* Contraindications to neuraxial anesthesia\n* Preterm delivery (\\<37 weeks gestation)\n* Anticipated fetal-neonatal complex care plan\n* Participating in another pain intervention trial\n* Hypertensive disorder of pregnancy\n* Pre-eclampsia with severe features\n* Hemodynamic instability\n* Medical History exclusions: ketamine or PCP (phencyclidine) abuse, schizophrenia or psychosis, liver or renal insufficiency, uncontrolled hypertension, chest pain, arrhythmia, head trauma, or intracranial hypertension, uncontrolled thyroid disease, or other contraindications to ketamine",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Amy Monroe, MPH, MBA",
                    "role": "CONTACT",
                    "phone": "4126236382",
                    "email": "monroeal@upmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Grace Lim, MD, MSc",
                    "affiliation": "University of Pittsburgh",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Magee Womens Hospital of UPMC",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15213",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Minhnoi Wroble Biglan, PhD",
                            "role": "CONTACT",
                            "phone": "412-641-1777",
                            "email": "wroblebiglanm@upmc.edu"
                        },
                        {
                            "name": "Amy Monroe",
                            "role": "CONTACT",
                            "phone": "4126236382",
                            "email": "monroeal@upmc.edu"
                        },
                        {
                            "name": "Grace Lim, MD, MSc",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Deidentified data will be available for public benefit and knowledge. Items for uploading will include clinical measures, patient reported outcomes, psychometric testing data, sensory testing data, and all PK data. Technical protocols and any other data collected under this project will be shared upon request to allow others to perform secondary analyses.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "CSR"
            ],
            "timeFrame": "Beginning with 3 months and ending at 5 years following article publication.",
            "accessCriteria": "Researchers who propose a methodologically sound proposal may submit said proposals to limkg2@upmc.edu. To gain access to data, requestors will need to sign a data access agreement."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019052",
                    "term": "Depression, Postpartum"
                },
                {
                    "id": "D000010149",
                    "term": "Pain, Postoperative"
                },
                {
                    "id": "D000003863",
                    "term": "Depression"
                },
                {
                    "id": "D000003866",
                    "term": "Depressive Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001526",
                    "term": "Behavioral Symptoms"
                },
                {
                    "id": "D000019964",
                    "term": "Mood Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000011183",
                    "term": "Postoperative Complications"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000011644",
                    "term": "Puerperal Disorders"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7058",
                    "name": "Depression",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7061",
                    "name": "Depressive Disorder",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13069",
                    "name": "Pain, Postoperative",
                    "asFound": "Pain, Postoperative",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M21076",
                    "name": "Depression, Postpartum",
                    "asFound": "Depression, Postpartum",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4818",
                    "name": "Behavioral Symptoms",
                    "relevance": "LOW"
                },
                {
                    "id": "M21835",
                    "name": "Mood Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14065",
                    "name": "Postoperative Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M14499",
                    "name": "Puerperal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007649",
                    "term": "Ketamine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000778",
                    "term": "Anesthetics, Dissociative"
                },
                {
                    "id": "D000018686",
                    "term": "Anesthetics, Intravenous"
                },
                {
                    "id": "D000018681",
                    "term": "Anesthetics, General"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000018691",
                    "term": "Excitatory Amino Acid Antagonists"
                },
                {
                    "id": "D000018683",
                    "term": "Excitatory Amino Acid Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10674",
                    "name": "Ketamine",
                    "asFound": "Nerve",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4108",
                    "name": "Anesthetics, Dissociative",
                    "relevance": "LOW"
                },
                {
                    "id": "M20766",
                    "name": "Anesthetics, Intravenous",
                    "relevance": "LOW"
                },
                {
                    "id": "M20761",
                    "name": "Anesthetics, General",
                    "relevance": "LOW"
                },
                {
                    "id": "M20771",
                    "name": "Excitatory Amino Acid Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}